I'm excited to announce the first ever BioML Fellowship 🧬💰🧬. We at the @biomlsociety have been working with Texas Biologics and @TexasScience over the past few months to create a fellowship that helps PhD students at UT Austin become leaders in the emerging field of BioML

Announcing the BioML Challenge 2024: Bits to Binders!. In this 5-week competition, teams will use AI methods to design protein binders that bind to a target antigen and activate an immune response from its associated CAR-T cell. Real-world scenario. With wet lab validation.

Good software should be fast, reliable, reusable, and maintainable. A lot of BioML benchmarking is uh… not. But biology doesn’t standardize to a few data types like language, audio, or images. We’re constantly inventing new ways to measure life. 1/n

Introducing Open Molecules 25, a foundational quantum chemistry dataset including >100M DFT calculations across 83M unique molecules, built with 6B core hours of compute!. What does this mean for drug discovery, biology, and BioML?. 1/

The first day of our bioML symposium at @IOCBPrague went very well. It is amazing to see how fast this field is moving forward. Thanks to everyone for the fantastic talks! 🤖🧬

Packed audience this past Monday for @saakohl’s talk for the BioML seminar! Lots of insights about how to structure good problems at the interface of ML and bio, lessons from building AlphaFold2, and what he’s building now at Latent Labs!

Last year I made an intro Protein + ML project to teach BioML Society members about protein embeddings. Here it is! Hope you all enjoy . Should get you familiar extracting embeddings for proteins, visualizing them, and using them for property prediction

And we're off! The design stage of the BioML Challenge 2024: Bits to Binders began this past Saturday. 62 teams will be using AI methods to design ~300 de novo antigen binders for human CD20. We will be screening a total of *18,000* unique designs with the help of @LEAHLabsInc

The last few months have been intense, the good kind of intense. I am over the moon to share that I joined the BioML team at @altos_labs . I am thrilled by the mission which has the potential to be a paradigm change in medicine 😍

Since March 2024, I’ve collected 357 molecular ML papers (protein/RNA/DNA/small molecules). 2024 has definitely been a milestone year for BioML/protein design, with a significant boost of papers (likely over 1K😆), so many impressive works, and increased attention for the entire

We are presenting 5 papers @iclr_conf on AI4Bio / BioML: Interpretable LLMs, all-atom latent diffusion, Agents, & guided sampling from foundation models. 🧵1/

Four of my favorite BioML preprints from this week:. 1. One-shot design of protein binders—achieving nanomolar affinity without any experiments. Credit to co-first author @MartinPacesa for the epic video!

Four more days to apply to be a PhD intern in the BioML group at MSR!.

Achievement Unlocked!! 🤘🤘🤘. 🌱🌱 **10,547+ AI jobs run today** 🌱🌱. 💬 Questions. 🎨 Images. 🎥 Videos. 🤖 Agents. 🧪 BioML. 🐸All powered by Lilypad. 🌐 The future is open innovation

🧬 How do you diagnose a disease when the symptoms are vague, the genetics are rare, and the biology is complex?. At Rare Compute, we're developing METEOR — an experimental BioML system designed to help answer that question for Inborn Errors of Metabolism (IEMs). Here's how

It was great meeting with @martintrevor_, Mammoth Biosciences co-founder and CEO, yesterday. So many gold-nuggets on CRISPR, bioML, and early-stage startup execution 🚀

A ray of light on a gloomy and rainy day in Zurich is a good Italian pizza with the best bioML team in the world ⁦@vant_ai⁩

It was fun meeting @tunguz and his family for lunch in Bloomington! . Had some interesting discussions about NVIDIA, BioML, and of course XGBoost 😉

Today is the registration deadline for our bioML symposium on Aug 21-22. Last chance to secure your spot! More info at